| Patents for A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids) (127,169) |
|---|
| 04/27/2005 | EP1040098B1 Integrin receptor antagonists |
| 04/27/2005 | EP0994853B1 A monoether of probucol and methods for the inhibition of the expression of vcam-1 |
| 04/27/2005 | EP0906307B1 Substituted imidazoles having cytokine inhibitory activity |
| 04/27/2005 | EP0850068B1 Lipid extract having anti-inflammatory activity |
| 04/27/2005 | EP0838453B1 Heterocyclic carboxylic acid derivatives and drugs containing the same |
| 04/27/2005 | CN1610751A Method for measuring serine palmitoyltransferase in mammalian tissue and use thereof |
| 04/27/2005 | CN1610675A Benzothiazole- and benzoxazole-4, 7-dione derivatives and their use as CDC25 phosphatase inhibitors |
| 04/27/2005 | CN1610674A Use of 2-amino-thiazoline derivatives as inhibitors of inducible NO-synthase |
| 04/27/2005 | CN1610670A 4-phenyl-pyridine derivatives as neurokinin-1 receptor antagonists |
| 04/27/2005 | CN1610668A Substituted propane-1, 3-diamine derivatives and the pharmaceutical use |
| 04/27/2005 | CN1610661A Allenic aryl sulfonamide hydroxamic acids as matrix metalloproteinase and TACE inhibitors |
| 04/27/2005 | CN1610659A Carboxylic acid derivative |
| 04/27/2005 | CN1610551A Parenteral administration of 6-hydroxy-oxymorphone for use as an analgesic |
| 04/27/2005 | CN1610544A Method for preventing and treating visceral pain and gastrointestinal disorders |
| 04/27/2005 | CN1610502A Surfactant protein for the prevention and diagnosis of pulmonary emphysema |
| 04/27/2005 | CN1608668A Chinese medicine oral powder and plaster for treating rheumatism and rheumatoid disease and their prepn process |
| 04/27/2005 | CN1608662A Medicine with antiphlogistic, analgetic, microbiostatic and diuretic effects |
| 04/27/2005 | CN1608656A Health care liquid for rheumatism |
| 04/27/2005 | CN1608655A Chinese medicine for treating rheumatism |
| 04/27/2005 | CN1608619A Medicine recipe with baicalin |
| 04/27/2005 | CN1608513A Health food containing hyaluronic acid and dermatan sulfate |
| 04/27/2005 | CN1198832C New amino propylphosphinic acid |
| 04/27/2005 | CN1198821C Process for preparation of sulfonamide derivs. and crystals thereof |
| 04/27/2005 | CN1198820C N-substituted nitrogen heterocyclic compound |
| 04/27/2005 | CN1198819C Benzimidazole derivatives |
| 04/27/2005 | CN1198818C Compound with growth hormone releasing properties |
| 04/27/2005 | CN1198817C N-(imidazolylalkyl) substituted cyclic amines as histamine-H3 agonists or antagonists |
| 04/27/2005 | CN1198807C 5-aryl-1H-1,2,4-triazole compounds as inhibitors of cyclooxygenase-2 and pharmaceutical composition containing the same |
| 04/27/2005 | CN1198804C Amide compounds and use thereof |
| 04/27/2005 | CN1198647C Antibodies against human CD40 |
| 04/27/2005 | CN1198646C Identification of unique binding interactions between certain antibodies and the human B7.1 and B7.2 co-stimulatory antigens |
| 04/27/2005 | CN1198625C Pharmaceutical compositions for treatment of mucositis, stomatitis and Behchet's syndrome |
| 04/27/2005 | CN1198618C Novel use of 1-[4-(5-cyanoindol-3-yl)butyl]-4-(2-carbamoyl-benzofuran-5-yl)-piperazine and its physiologically acceptable salts |
| 04/27/2005 | CN1198614C Method for treating inflammatory diseases using pADPRT inhibitors |
| 04/27/2005 | CN1198592C Process for producing particles with converted amorphous and/or meta-stable drystalline region into crystalline state |
| 04/27/2005 | CN1198589C Method for controlling liposome size |
| 04/27/2005 | CN1198588C Multilayer emulsion for stabilization of effective component on dermatology and externally used preparation using it |
| 04/27/2005 | CN1198586C Topical compositions for NSAI drug delivery |
| 04/27/2005 | CN1198583C Milling process for production of finely milled medicinal substances |
| 04/26/2005 | US6884910 Uses for amino acid anticonvulsants |
| 04/26/2005 | US6884907 Containing carboxylic acid groups; diagnosis; prophylaxis |
| 04/26/2005 | US6884808 Acids and salts such as 4-(4-(2-(2-(5,6,7,8-Tetrahydro-5,5,8, 8-tetramethylquinoxalyl))pyrrolyl))benzoic acid, used retinoic acid receptor agonists for the prophylaxis of cancer, skin disorders, asthma, alopecia or autoimmune diseases |
| 04/26/2005 | US6884807 3-bicyclic carbocyclic group substituted quinuclidine derivatives, which are cholinergic ligands at the nicotinic acetylcholine receptors and modulators of the monoamine receptor and transporters |
| 04/26/2005 | US6884804 Inhibitors of Src and other protein kinases |
| 04/26/2005 | US6884802 Phenanthridines substituted in position 6 by a mono, bi- or tricyclic heteroaryl radical; cyclic nucleotidephosphoesterase (PDE4) inhibitor and useful for treating respiratory system disorders |
| 04/26/2005 | US6884800 Nitrogen compounds such as 10-Chloro-3-imidazol-1-yl-2,3-dihydro-1H-pyrido(3,2,1-kl)phenothiazine, used for prophylaxis of respiratory system and skin disorders, autoimune diseases, tumors or atherosclerosis and AIDS |
| 04/26/2005 | US6884785 Compositions and methods for the treatment or prevention of autoimmune diabetes |
| 04/26/2005 | US6884574 Methods of identifying agents which inhibit GPR-9-6 |
| 04/26/2005 | US6884413 Immunosuppressants for organ transplantions by inducing apoptosis/anergy in T cells; genetic engineering; antigen presenting cells |
| 04/26/2005 | US6884408 Delivery of diphenhydramine through an inhalation route |
| 04/26/2005 | CA2244134C Diphenyl stilbenes as prodrugs to cox-2 inhibitors |
| 04/26/2005 | CA2239053C Diphenyl pyridyl ethane derivatives as pde iv inhibitors |
| 04/21/2005 | WO2005035586A1 Fused protein composition |
| 04/21/2005 | WO2005035582A1 Composition of antibody capable of specifically binding ccr4 |
| 04/21/2005 | WO2005035536A1 Novel xanthone derivative, process for producing the same and pharmaceutical composition containing the same |
| 04/21/2005 | WO2005035527A1 Substituted pyrazinone compounds for the treatment of inflammation |
| 04/21/2005 | WO2005035518A1 Rearranged pentanols, a method for the production thereof, and their use as antiphlogistics |
| 04/21/2005 | WO2005035516A1 Novel fused heterocyclic compound and use thereof |
| 04/21/2005 | WO2005035510A1 Derivatives of 4-phenylthiazoles and 4-phenylimidazoles and the use thereof as medicaments for treating neurodegenerative diseases, pain and epilepsy |
| 04/21/2005 | WO2005035503A1 Novel isoquinoline derivative |
| 04/21/2005 | WO2005035502A1 1-(quinoline amino) and 1-(isoquinoline amino)-substituted pentan-2-ols, method for their production and their use as anti-inflammatories |
| 04/21/2005 | WO2005035471A1 Ether derivative |
| 04/21/2005 | WO2005035003A2 Compositions and methods for increasing drug efficiency |
| 04/21/2005 | WO2005034952A2 Isoxazole and isothiazole compounds useful in the treatment of inflammation |
| 04/21/2005 | WO2005023741A3 Pharmaceutical compositions containing (+) cannabidiol and derivatives thereof and some such novel derivatives |
| 04/21/2005 | WO2005009421A3 The use of 1-amino-alkylcyclohexane compounds in the treatment of pain hypersensitivity |
| 04/21/2005 | WO2004110995A8 N-pyrrolidin-3-yl-amide derivatives as serotonin and noradrenaline re-uptake inhibitors |
| 04/21/2005 | WO2004108119A3 Use of atp or derivatives in medicine |
| 04/21/2005 | WO2004105678A3 Pharmaceutical composition based on ketorolac or one of its salts pharmaceutically acceptable and use of ketorolac or its salts in pharmaceutical compositions |
| 04/21/2005 | WO2004089286A3 Novel compounds and compositions as protein kinase inhibitors |
| 04/21/2005 | WO2004005313A3 Hybrid molecules of macrolides with steroid/non-steroid anti-inflammatory, antineoplastic and antiviral active molecules |
| 04/21/2005 | US20050085758 Dilute aqueous solution containing epidermal growth factor in gel |
| 04/21/2005 | US20050085667 N-biphenylmethyl aminocycloalkanecarboxamide derivatives |
| 04/21/2005 | US20050085639 Circulation disorders; antiproliferative agents; hypotensive agents; cardiovascular disorders; antiischemic agents; kidney disorders; atherosclerosis; restenosis; antiinflammatory agents; respiratory system disorders; angiogenesis inhibitors; anticancer agents; antiulcer agents |
| 04/21/2005 | US20050085637 Pyrimidine compounds |
| 04/21/2005 | US20050085531 Thiophene-based compounds exhibiting ATP-utilizing enzyme inhibitory activity, and compositions, and uses thereof |
| 04/21/2005 | US20050085512 Amides that inhibit vanilloid receptor subtype 1 (VR1) receptor |
| 04/21/2005 | US20050085509 KInase inhibitors; antiarthritic agents; autoimmune diseases; sepsis; cachexia; Alzheimer's disease; antihistamines; thrombosis; glomerulonephritis; inflammatory bowel disorders; crohn's disese; multiple sclerosis; antitumor agents; skin disorders |
| 04/21/2005 | US20050085505 Quinoline derivatives, process for preparing them and use for the treatment of diseases mediated by s-cd23 |
| 04/21/2005 | US20050085493 Quinazolinone derivatives and their use as cb agonists |
| 04/21/2005 | US20050085487 Heterocyclic compounds |
| 04/21/2005 | US20050085480 Water-soluble phenylpyridazine compounds and compositions containing the same |
| 04/21/2005 | US20050085476 Polymerase inhibitors; antiischemic agents; brain disorders; cardiovascular disorders; antiinflammatory agents; antiarthritic agents; neurodegenerative agents; Alzheimer's disease; muscular disorders; antidiabetic agents; kidney disorders; viricides; anticancer agents; immunosuppressants |
| 04/21/2005 | US20050085471 Using 2-morpholinyl-4H-pyrido(1,2-a)pyrimidin-4-one; enzyme inhibitors; antithrombotic agents ; restenosis; atherosclerosis; antihistamines; chronic obsessive pulminary disease; autoimmune diseases; anticancer agents; antiinflammatory agents |
| 04/21/2005 | US20050085469 Fused bicyclic pyrimidine derivatives |
| 04/21/2005 | US20050085460 useful as therapeutics in treatment of cancers and the amelioration of the effects of stroke, head trauma, and neurodegenerative disease |
| 04/21/2005 | US20050085440 Formulation |
| 04/21/2005 | US20050085423 Administering an amide ciompound ; analgesics; antiinflamamtory agents |
| 04/21/2005 | US20050084897 DNA encoding human vanilloid receptor VR3 |
| 04/21/2005 | US20050084552 Pharmaceutical composition of chinese herbs for treating snuffle, headache and the use thereof |
| 04/21/2005 | US20050084523 Inhaling formulation providing analgesia to patient; contains one rapid-onset opioid and a sustained-effect opioid; avoiding toxicity while achieving analgesia, side effect occurs before the onset of toxicity; dispensers |
| 04/21/2005 | US20050084518 For producing beautiful skin and improving constipation, reducing hair loss |
| 04/21/2005 | US20050084489 Synergistic administration of Vitaxin, a FAB fragment, or a competitive binding antibody for binding integrin alpha V beta 3 with the enzyme inhibitor; antiinflammatory, anticarcinogenic agents; autoimmune and metabolic bone disorders |
| 04/21/2005 | US20050084486 Composition comprising alkaline sphingomyelinase for use as a dietetic preparation, food supplement or pharmaceutical product |
| 04/21/2005 | US20050084484 Administering Lactobacillus plantarum having catalase activity and superoxide dismutase activity as an antiinflammatory agent for rheumatic diseases and psoriasis |
| 04/21/2005 | US20050084482 As an antiinflammatory agent for gastrointestinal inflammation involved with inflammatory bowel disease or irritable bowel syndrome |
| 04/21/2005 | US20050084463 Antiinflammatory, antiarthritic agents, analgesics for pain caused by diabetic assoicated conditions, pneumoconiosis, angina, menstruation or cancer |
| 04/21/2005 | CA2542046A1 Fused protein composition |
| 04/21/2005 | CA2542037A1 Composition of antibody capable of specifically binding ccr4 |
| 04/21/2005 | CA2541667A1 Substituted pyrazinone compounds for the treatment of inflammation |